| Date | Ticker | Company | Drug | Type | Phase | PoA | Mkt Size | Notes |
|---|---|---|---|---|---|---|---|---|
|
2026-04-30 in 2 days |
AZN | AdCom | — | 92% | $8B | APR 30 2026 2 days 🏛️ AdCom Truqap (capivasertib (Truqap) + abir...) $AZN AstraZeneca PTEN | ||
|
2026-04-30 in 2 days |
AZN | AdCom | — | 85% | $12B | APR 30 2026 2 days 🏛️ AdCom (camizestrant (NDA 220359)) $AZN AstraZeneca HR+/HER2- advance | ||
|
2026-06-03 in 175 days |
CYTK | AdCom | — | 85% | $4B | JUN 3 2026 36 days 🏛️ AdCom MYQORZO (aficamten) $CYTK Cytokinetics Obstructive hypertrophi | ||
|
2026-08-20 in 392 days |
KALV | AdCom | — | 85% | $1B | AUG 20 2026 114 days 🏛️ AdCom (donidalorsen) $KALV KalVista Pharmaceuticals Hereditary ang |